Shelley Hancock, Clearside Biomedical, Inc. (E), Clearside Biomedical, Inc. (I);
Avinash Phadke, Achillion Pharmaceuticals (E), Achillion Pharmaceuticals (P), Achillion Pharmaceuticals (I);
Viral Kansara, Clearside Biomedical, Inc. (E), Clearside Biomedical, Inc. (I);
David Boyer, Achillion Pharmaceuticals (E), Achillion Pharmaceuticals (P), Achillion Pharmaceuticals (I);
Jose Rivera, Achillion Pharmaceuticals (E), Achillion Pharmaceuticals (P), Achillion Pharmaceuticals (I);
Christopher Marlor, Achillion Pharmaceuticals (E), Achillion Pharmaceuticals (P), Achillion Pharmaceuticals (I);
Steven Podos, Achillion Pharmaceuticals (E), Achillion Pharmaceuticals (P), Achillion Pharmaceuticals (I);
Jason Wiles, Achillion Pharmaceuticals (E), Achillion Pharmaceuticals (P), Achillion Pharmaceuticals (I);
Rick McElheny, Clearside Biomedical, Inc. (E), Clearside Biomedical, Inc. (I);
Thomas Ciulla, Clearside Biomedical, Inc. (E), Clearside Biomedical, Inc. (I);
Mingjun Huang, Achillion Pharmaceuticals (E), Achillion Pharmaceuticals (P), Achillion Pharmaceuticals (I);
Mark Cartwright, Achillion Pharmaceuticals (E), Achillion Pharmaceuticals (P), Achillion Pharmaceuticals (I)